Many Americans Medical Data and Images Are Easily Accessible Online. What Does This Mean for Rare Disease Patients?

According to a story from ProPublica, the computer servers that store important patient medical data are surprisingly unprotected. This lack of protection appears to be a problem around the world,…

Continue Reading Many Americans Medical Data and Images Are Easily Accessible Online. What Does This Mean for Rare Disease Patients?
A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses
mcmurryjulie / Pixabay

A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses

According to a post from gaucherdisease.org, clinical trials are an essential component to the development and testing of new therapies for Gaucher disease and other rare diseases. For some rare…

Continue Reading A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses

In Honor of Tay-Sachs Disease Awareness Month Organizations are Teaming Together to Spread Awareness of Genetic Testing

Tay-Sachs Disease September is Tay-Sachs Disease Awareness Month. Voted on by the Senate unanimously in 2008, this month aims to spread awareness about this disease and the importance of carrier…

Continue Reading In Honor of Tay-Sachs Disease Awareness Month Organizations are Teaming Together to Spread Awareness of Genetic Testing
After Visiting Nearly 100 Doctors, This Man Still Doesn’t Have a Diagnosis for His Rare Disease
Free-Photos / Pixabay

After Visiting Nearly 100 Doctors, This Man Still Doesn’t Have a Diagnosis for His Rare Disease

According to a story from the Washington Post, Bob Schwartz is a walking, talking medical mystery. He lives with a strange and diverse array of difficult symptoms, and after being…

Continue Reading After Visiting Nearly 100 Doctors, This Man Still Doesn’t Have a Diagnosis for His Rare Disease

Kisaco Research’s Rare Disease Diagnostics Summit

  • Post author:
  • Post category:

Rare Disease Diagnostics Summit "Reducing the Diagnostic Odyssey to Improve Patient Outcomes" Boston, Massachusetts The diagnostic component of genetic rare diseases must be addressed. More than 350 million people are…

Continue Reading Kisaco Research’s Rare Disease Diagnostics Summit
Company Earns Breakthrough Device Designation for Pulmonary Arterial Hypertension
Bokskapet / Pixabay

Company Earns Breakthrough Device Designation for Pulmonary Arterial Hypertension

According to a story from Benzinga, the medical device company V-Wave Ltd. has recently announced that a product in development by the company has earned Breakthrough Device designation from the…

Continue Reading Company Earns Breakthrough Device Designation for Pulmonary Arterial Hypertension
ICYMI: FDA Approves Expanded Access Application of Experimental Niemann-Pick Type C Drug
rawpixel / Pixabay

ICYMI: FDA Approves Expanded Access Application of Experimental Niemann-Pick Type C Drug

According to a press release from CTD Holdings, the American Food and Drug Administration (FDA) recently approved an Expanded Access application from a physician to treat a pediatric Niemann-Pick disease…

Continue Reading ICYMI: FDA Approves Expanded Access Application of Experimental Niemann-Pick Type C Drug

Cambridge Rare Disease Network’s RARESummit 2019

  • Post author:
  • Post category:

RARESummit 2019 Patients as Partners RARESummit 2019 is a rare disease conference unlike any other. The emphasis of this event is patient-centricity and partnership in the process of rare disease…

Continue Reading Cambridge Rare Disease Network’s RARESummit 2019
Specialty Pharmacists Play Important Role in Treatment of Primary Immunodeficiency Patients
qimono / Pixabay

Specialty Pharmacists Play Important Role in Treatment of Primary Immunodeficiency Patients

A recent publication from Specialty Pharmacy Times noted that the rapidly-growing number of available human immunoglobulin treatments for primary immunodeficiency disorders could pose challenges for specialty pharmacists when treating patients.…

Continue Reading Specialty Pharmacists Play Important Role in Treatment of Primary Immunodeficiency Patients
NHS Finally Reverses Almost 2 Year Policy Against Offering Cerliponase Alfa to Batten Disease Patients
source: pixabay.com

NHS Finally Reverses Almost 2 Year Policy Against Offering Cerliponase Alfa to Batten Disease Patients

According to a recent publication from Express Digest, England's National Health Service (NHS) has reversed its earlier position on a rare disease drug after lengthy public debate, now agreeing to…

Continue Reading NHS Finally Reverses Almost 2 Year Policy Against Offering Cerliponase Alfa to Batten Disease Patients
 A New Path to Helping Patients with Rare Diseases 
https://pixabay.com/en/hand-united-together-people-unity-1917895/

 A New Path to Helping Patients with Rare Diseases 

By: Maria Palombini, IEEE-Standards Association  For more than a decade there has been much propaganda on educating and encouraging patients to manage their healthcare. This was a direct shift in response…

Continue Reading  A New Path to Helping Patients with Rare Diseases 

Global Genes’ RARE Patient Advocacy Summit

  • Post author:
  • Post category:

The Global Genes RARE Patient Advocacy Summit This conference will be a convergence of a variety of rare disease stakeholders, such as rare disease patients, world renowned experts, and caregivers.…

Continue Reading Global Genes’ RARE Patient Advocacy Summit
Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Free-Photos / Pixabay

Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says

According to a story from Medscape, a recent study is highlighting the fact that many thyroid cancer survivors are still worried about cancer-related problems years after the conclusion of treatment.…

Continue Reading Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1
RoyBuri / Pixabay

Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1

According to a story from wearegreenbay.com, a team of scientists associated with the University of Wisconsin, Madison are undertaking a project that will help improve the effectiveness of research related…

Continue Reading Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1